Kenneth Gordon to Global Health
This is a "connection" page, showing publications Kenneth Gordon has written about Global Health.
Connection Strength
0.092
-
The first World Psoriasis and Psoriatic Arthritis Conference. J Invest Dermatol. 2007 Jul; 127(7):1566-7.
Score: 0.068
-
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease. Ann Rheum Dis. 2013 Apr; 72(4):517-24.
Score: 0.024